Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208897 · ClinicalTrials.gov registry record · NA
Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00208897 is a NA study that has completed, run by Emory University. The registered enrollment target is 80 participants.
The verdict
NCT00208897, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The primary objective of this project is to determine whether treatment with the SSRI, fluoxetine versus placebo reverses alterations in the central CRF system induced by early life stress experiences (i.e. childhood sexual and/or physical abuse) in cases with and without major depression. We also evaluate whether neuroendocrine changes after SSRI treatment correlate with clinical improvement.
Interventions
- DRUG Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 1997-12 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208897
The ClinicalTrials.gov registry entry for NCT00208897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluoxetine is the first listed.
NCT00208897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208897 about?
NCT00208897 is a clinical study titled "Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?". The primary objective of this project is to determine whether treatment with the SSRI, fluoxetine versus placebo reverses alterations in the central CRF system induced by early life stress experiences (i.e. childhood sexual and/or physical abuse) in cases with and without major depression. We also e...
What is the current status of trial NCT00208897?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 1997-12. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00208897?
The interventions under investigation include: Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00208897?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.